Mavrilimumab (Anti-CSF2Ra/GM-CSFRa/CD116)

Mavrilimumab (Anti-CSF2Ra/GM-CSFRa/CD116) is a monoclonal antibody that binds to the α subunit of the granulocyte-macrophage colony stimulating factor (GM-CSF) receptor and blocks intracellular signalling downstream of GM-CSF. MW: 145.5 KD.

Trivial name CAM 3001
Catalog Number A2532
CAS# 1085337-57-0
Size 1mg*25
Supplier Page http://www.selleckchem.com/products/mavrilimumab-anti-csf2ra-gm-csfra-cd116.html